Stepholidine: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
No edit summary |
||
| Line 25: | Line 25: | ||
{{stub}} | {{stub}} | ||
== Stepholidine == | == Stepholidine == | ||
<gallery> | <gallery> | ||
File:(−)-Stepholidine.svg|(−)-Stepholidine | File:(−)-Stepholidine.svg|(−)-Stepholidine | ||
</gallery> | </gallery> | ||
Latest revision as of 00:58, 17 March 2025
Stepholidine is a tetrahydroprotoberberine alkaloid that is found in the Stephania genus of plants. It is notable for its dual action as a dopamine receptor agonist and antagonist, and has been studied for its potential use in the treatment of Parkinson's disease and drug addiction.
Chemistry[edit]
Stepholidine is a member of the tetrahydroprotoberberine class of alkaloids, which also includes compounds such as palmatine and berberine. It is a dimer of two protoberberine units, and is structurally similar to other alkaloids found in the Stephania genus.
Pharmacology[edit]
The unique pharmacological profile of stepholidine is due to its dual action as a dopamine receptor agonist and antagonist. It acts as an agonist at the D1 receptor, and as an antagonist at the D2 receptor. This dual action is thought to be responsible for its potential therapeutic effects in conditions such as Parkinson's disease and drug addiction.
Therapeutic potential[edit]
Research into the therapeutic potential of stepholidine has focused on its effects on the dopamine system. In animal models of Parkinson's disease, stepholidine has been shown to improve motor function and reduce dyskinesia. It has also been studied for its potential to reduce drug-seeking behavior in models of addiction.
Safety[edit]
The safety of stepholidine in humans has not been fully established. However, studies in animals have suggested that it is well-tolerated and has a low potential for toxicity.


